Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Forward Therapeutics, Inc (“Forward” or “the Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced the successful ...

Tumor necrosis factor (TNF) inhibitors protect patients with axial spondyloarthritis (axSpA) from hip and spine fractures better than other drugs. Large US insurance claims database study comparing ...

TNF Pharmaceuticals, Inc. (TNFA) announced on Wednesday that it has changed its corporate name to Q/C Technologies and will begin trading under a new ticker on the Nasdaq Capital Market starting ...

Christian McCaffrey, Mac Jones and San Francisco 49ers visit the Los Angeles Rams led by Matthew Stafford and Davante Adams tonight in a Thursday Night Football showdown to begin Week 5 of the NFL ...

For years, the NFL took up two days of the week - Sunday and Monday - with the latter only one game at night. Exception was made for Thanksgiving as the Detroit Lions and Dallas Cowboys each hosted a ...

PALM BEACH GARDENS, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Forward Therapeutics, Inc (“Forward”), a biotechnology company developing oral small molecule therapies for inflammation-driven diseases, ...

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune ...

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune ...